Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the network for surveillance of pneumococcal disease in the East African Region

Clinical Infectious Diseases

Volumn 48, Issue SUPPL. 2, 2009, Pages

  Mudhune, Sandra ^a   Wamae, Maranga ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

AFRICA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD SAMPLING; CEREBROSPINAL FLUID CULTURE; CHILD; DISEASE SURVEILLANCE; FEMALE; GROUPS BY AGE; HAEMOPHILUS INFLUENZAE; HEALTH CARE ORGANIZATION; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PUBLIC HEALTH; SEROTYPE; STREPTOCOCCUS PNEUMONIA; VACCINATION;

AFRICA, EASTERN; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BLOOD; CEREBROSPINAL FLUID; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; INFANT, NEWBORN; MENINGITIS, HAEMOPHILUS; MENINGITIS, PNEUMOCOCCAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 61849171762     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/596494     Document Type: Article

References (8)

1. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13:302-17.
2. Paedeatric BacterialMeningitis (PBM) Surveillance Network Web page. Available at: http://www.afro.who.int/hib/. Accessed 29 December 2008.
3. A manual for the laboratory identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance in developing world. Geneva, Switzerland: World Health Organization, 2003: 255-8.
4. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement (M100-S18). Wayne, PA: Clinical Laboratory Standards Institute, 2008.
5. Ben Amos AK, Makewa D, Mudhune S, et al. Behind the data: establishing the Network for Surveillance of Pneumococcal Disease in the East African Region, netSPEAR. Clin Infect Dis (in this supplement).
6. Hausdorff WP. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine 2007; 25:2406-12.
7. Hausdorff WP, Bryant J, Kkowek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000; 30:122-40.
8. Pneumococcal conjugate vaccine for childhood immunization - World Health Organization position paper, 2007. Geneva, Switzerland: World Health Organization, 2007; 82:93-104.